Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression
S Padeh, R Theodor, A Jonas… - Archives of disease in …, 1997 - adc.bmj.com
S Padeh, R Theodor, A Jonas, JH Passwell
Archives of disease in childhood, 1997•adc.bmj.comA 15 year old boy with autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy
syndrome suffered recurrent episodes of severe intractable diarrhoea, steatorrhoea, and
hypocalcaemia. The only treatment modality, which controlled the malabsorption syndrome,
was immunosuppression with intravenous high dose methylprednisolone and oral
methotrexate maintenance therapy.
syndrome suffered recurrent episodes of severe intractable diarrhoea, steatorrhoea, and
hypocalcaemia. The only treatment modality, which controlled the malabsorption syndrome,
was immunosuppression with intravenous high dose methylprednisolone and oral
methotrexate maintenance therapy.
A 15 year old boy with autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome suffered recurrent episodes of severe intractable diarrhoea, steatorrhoea, and hypocalcaemia. The only treatment modality, which controlled the malabsorption syndrome, was immunosuppression with intravenous high dose methylprednisolone and oral methotrexate maintenance therapy.
adc.bmj.com
